is efficacious for lysis of coronary thrombi and pulmonary emboli, relatively high concentrations are required.1-3 This may result in part from the paucity of fibrin binding sites for t-PA on the surface of whole blood clots. 4 In the absence of binding to fibrin, t-PA has greatly reduced efficacy in activating plasminogen and inducing clot lysis.5 In clinical practice, t-PA can be directly injected into the site of thrombus with percutaneous transluminal catheters rather than infused systemically.6'7 Presumably this approach improves lysis by increasing the surface area of fibrin available for t-PA binding.
Ultrasound has been used without exogenous t-PA to disrupt peripheral arterial and venous thrombi in animal models8-1" and to open atherosclerotic occlusions of peripheral arteries in selected patients.12,13 To achieve these effects, ultrasound was used at a frequency (20 kHz) and intensity that caused cavitation, thereby dis-rupting tissues with low elasticity, such as atheromas and thrombi. '3,'4 The ultrasound was delivered through catheters to prevent damage to normal tissues near the sites of the occlusions. are the first to report the use of noninvasive ultrasound to increase the efficacy of systemic t-PA. They found that transcutaneous ultrasound that was delivered in a continuous mode at a frequency of 200 kHz could enhance t-PA-induced fibrinolysis in a canine model of femoral arterial thrombi. [15] [16] [17] Ultrasound that is used in physiotherapy is delivered at a frequency of 1 MHz, which can cause acoustic streaming, or wave-medium interactions that promote agitation of solute and microparticulate matter without inducing cavitation or tissue damage.18 This property of ultrasound suggested that it might have the potential for gentle perturbation of a clot, which would expose additional fibrin for t-PA binding. The ability of noninvasive ultrasound, delivered at a frequency of 1 MHz in an intermittent mode, to enhance t-PA activity was therefore studied in vitro and in vivo using the rabbit jugular from Genentech, Inc., South San Francisco, Calif.; thrombin (2, 200 After incubation at 22°C for 2 hours, the clots were added to two beakers that were in a water bath maintained at 37°C (Figure 1 ). The beakers each contained 100 ml supernatant. In one of the two beakers, the ultrasound transducer was placed into direct contact with the supernatant, and the clot was at the bottom of the conical beaker, or 6 cm from the face of the transducer. The surface area of each beaker was 43 cm2.
The walls of the Pyrex beakers were 2 mm thick, and the angle between each beaker and the external perpendicular support was 23°C. Conical beakers were used so that the thrombus would not drift out of the range of the ultrasound beam. (1 , uCi) 2'I-labeled human fibrinogen and kept on ice to prevent clotting. Next, the jugular vein was atraumatically occluded proximal and distal to the facial vein with microvascular clamps (Scanlan International, Inc., St. Paul, Minn.). A 4-0 silk thread soaked in human thrombin solution was placed into a small polyethylene catheter, which was inserted into the venotomy in the facial vein and guided into the jugular vein. The radiolabeled blood (0.5 ml) was introduced into the jugular vein through the facial vein to create a thrombus around the 4-0 silk thread. The catheter in the facial vein was removed, the facial vein was ligated around the thread, and the end of the thread was brought out to the skin through a small puncture to facilitate percutaneous removal at the completion of the experiment. The microvascular clamps were removed, and the skin was closed.
A temperature probe (2400 series temperature probe, Electromedics, Inc., Englewood, Colo.) to be used for temperature monitoring during the experiment was inserted into the neck through a separate skin puncture. The animal to receive ultrasound was positioned on a specially designed treatment table with an enclosed water bath maintained at 36.5-38.5°C ( Figure 2 ). The other animal was positioned in a similar fashion on a circulating water warming blanket also maintained at 36.5-38.50C.
Experimental protocol. To determine the effect of ultrasound on t-PA-induced fibrinolysis, a series of paired experiments were performed in which both animals received t-PA and one of each pair received ultrasound in addition to the t-PA. Intermittent ultrasound (1 MHz, 1.75 W/cm', with a 2-second on interval and a 2-second rest interval) was delivered throughout the experiment to the neck of the animal from a fixed transducer through a water bath 6 cm deep ( Figure 2 ). The distance was chosen so that the ultrasound beam could provide adequate coverage of the site of potential thrombosis in a human model. Controls for the rabbits receiving t-PA and ultrasound were four rabbits that received ultrasound and no t-PA.
In six paired experiments, animals received t-PA at a dose of 1 mg delivered intravenously during the first 30 minutes of the experiment. An additional six pairs of animals received t-PA at a dose of 2 mg. In this group, 1 mg t-PA was administered during the first 30 minutes, followed by 1 mg from 35 to 185 minutes. One control animal in this group died of postoperative respiratory insufficiency; therefore, only five paired studies are reported.
All animals received maintenance fluid and t-PA through a marginal ear vein cannula ipsilateral to the jugular vein thrombus. One milligram of t-PA was diluted in 5 ml of 0.3 M NaCl, 0.01% Tween 80 (Aldrich Chemical Co., Arlington Heights, Ill.) and administered with a constant-infusion pump (Sage Instruments, Cambridge, Mass.).
Fibrinolysis was monitored by obtaining a 2-minute count of radioactivity over the neck of each animal at time 0 (before the infusion of t-PA) with a calibrated gamma ratemeter (model 2221 scalar ratemeter, Ludlum Measurements, Inc., Sweetwater, Tex.).23 This was followed by serial counts throughout the experiment, with background counts obtained as well at each time point.
Percent lysis was calculated according to the following formula:
(cervical cpm time 0-cervical cpm time x) (cervical cpm time 0-background) Plasma fibrinogen and serum plasminogen were measured with functional assays as previously described.24
Toxicity Studies
To determine the extent of tissue injury sustained from insonation, the levels of creatinine phosphokinase (CPK; Encore Chemistry System, Baker Instruments, Inc., Allentown, Pa.) were measured in serum at times 0, 200 minutes, 24 hours, and 7 days in the pairs of rabbits receiving 1 mg t-PA in the presence and absence of ultrasound.
A blinded histological examination for pulmonary emboli was performed in four rabbits treated only with t-PA and in eight rabbits that received combined t-PA and ultrasound. Figure 1) . The 50-minute and 200-minute time points (the repeated-measures factor) were analyzed to determine early and late effects of insonation (reflecting rate and extent of fibrinolysis) for all in vitro experiments. Similar analyses were used for the in vivo data at 50 and 100 minutes, a time when fibrinolysis had reached a plateau. The (3, 30 , 300, and 3,000 IU/mI) to determine whether ultrasound affected the rate and extent of t-PA-induced fibrinolysis (Figure 3) . Differences in mean clot lysis caused by effects of ultrasound In paired experiments, clots were incubated with fresh frozen plasma to which t-PA had been added at a final concentration of 300 or 3,000 IU/ml, and one clot in each pair was exposed to intermittent ultrasound ( Figure 4 ). Ultrasound induced a significant increase in the extent of thrombolysis as determined with the repeated-measures ANOVA using 50-and 200-minute data at both t-PA concentrations [F(1,4)=36.9; p=0.004]. In all six paired experiments (three pairs at 300 IU/mi t-PA and three pairs at 3,000 IU/ml t-PA), the thrombus exposed to ultrasound and t-PA underwent greater lysis than the thrombus incubated with t-PA alone.
When clots were exposed to ultrasound and t-PA at a concentration of 300 IU/ml, the lysis at 200 minutes was 75+7% compared with 50+2% when clots were incubated with t-PA alone. Furthermore, ultrasound reduced the time to reach 50% lysis from 200 to 96 minutes.
For the clots exposed to t-PA at a final concentration of 3,000 IU/ml, the mean time to reach 50% lysis was reduced from 98 to 48 minutes in the presence of ultrasound. Clot lysis at 200 minutes was 91 ± 11% in the presence of insonation compared with 62±5% in the absence of ultrasound.
Fresh frozen plasma derived from a single donor was used in each paired experiment. The mean plasminogen concentration in the plasmas (n=6) used for these experiments was 3.8±0.2 CTA units/ml. In additional experiments, clots were incubated with t-PA (3,000 IU/ml) in Tris-albumin buffer containing purified plasminogen at a concentration of 1.2 CTA units/ml. The same degree of lysis was achieved at the lower concentration of plasminogen ( Table 1) .
The results of thrombolysis experiments with 3,000 IU/ml t-PA in Tris-albumin, plasma, and Tris-albumin containing plasminogen are summarized in Table 1 . In the absence of ultrasound, there was no significant 
Effect of Insonation on t-PA-Induced Thrombolysis In Vivo
Based on the in vitro studies, investigation of insonation effect on thrombolysis was extended in vivo using the rabbit jugular vein thrombosis model ( Figure  5 , Table 2 ). In addition to the paired groups of rabbits that received t-PA in the presence or absence of ultrasound, four rabbits received only ultrasound and no infusion of t-PA. In these four controls, clot lysis was 9±5% at 50 minutes and 6±10% at 100 minutes ( Table 2) .
Lysis in the rabbits that received 1 mg t-PA and ultrasound was increased at 50 minutes compared with that of rabbits receiving t-PA alone (41±14% versus 20±12%,p=0.12). The increase at 100 minutes, a time when lysis had reached a plateau, was sustained (55 ± 1% versus 30±12%, p=0.11). Furthermore, four of six pairs showed improved thrombolysis with ultrasound.
Clot lysis for the rabbits that received 2 mg t-PA and insonation compared with those that received only t-PA was 45±7% versus 28±11% (p=0.10) at 50 minutes and 50±12% versus 40±12% (p=0.29) at 100 minutes. Three of the five pairs showed improved thrombolysis with ultrasound.
Although the overall difference (repeated-measures ANOVA using data at 50 and 100 minutes for both t-PA doses) in mean thrombolysis between rabbits receiving insonation and t-PA and those receiving t-PA alone was not significant [F(1,9) =2.7;p=0.13], differences favored insonation at both 50 and 100 minutes for both doses of t-PA. The contrast between insonation and t-PA versus t-PA alone was greatest at 50 minutes [F(1,9)=3.45; p=0.09] when the combined data for the two doses were analyzed. The extent of thrombolysis in the group receiving t-PA at a dose of 2 mg was not different from that in the group receiving 1 mg (p=0.73).
The rabbits receiving 2 mg t-PA alone showed no significant change in the levels of plasminogen and fibrinogen between the beginning and the end of the experiment at 200 minutes. Fibrinogen levels were 2.2±0.2 mg/ml initially and then 1.6±0.3 mg/ml (p=0.13) at 200 minutes. Plasminogen levels were 3.9±0.3 CTA units/ml and then 3.7±0.2 CTA units/mi (p=0.6). The rabbits receiving ultrasound and t-PA showed significant changes in the levels of fibrinogen and plasminogen. The fibrinogen level decreased from 2.0±0.1 mg/ml at the beginning of the experiment to 1.1±0.3 mg/ml at 200 minutes (p=0.03). The plasminogen level decreased from 3.6±0.4 to 2.6±0.3 CTA units/ml (p=0.03). There was no significant change in the levels of fibrinogen or plasminogen in the four animals receiving ultrasound without t-PA. In this group, fibrinogen levels at the beginning and end of the experiment were 1.9±0.1 and 2.0±0.1 mg/ml (p=0.42), respectively, and the plasminogen levels were 4.2±0.3 and 4.0±0.2 CTA units/ml (p=0.33).
Investigation of Potential Insonation-Induced Injury
No increases in temperature were observed for animals receiving ultrasound and t-PA compared with those receiving only t-PA. There was no difference in the CPK values between rabbits receiving ultrasound and 1 mg t-PA and those receiving 1 mg t-PA alone. Pulmonary emboli were not detected histologically in 20 sections from the lungs of four rabbits treated only with t-PA. Two of the forty histological sections from eight rabbits that received combination t-PA and ultrasound The potential for the noninvasive use of ultrasound in conjunction with t-PA for the lysis of acute arterial occlusion has been demonstrated in a canine model in which both femoral arteries were occluded for 2 hours, mg/kg.15-'7 The application of transcutaneous continuous ultrasound (200 kHz) near the site of one of the occluded limbs in each animal was associated with an 80% decrease in the time required for recanalization.
The potential significance of noninvasive ultrasound delivered intermittently at a higher frequency is suggested by the present study. In the studies in vitro, intermittent ultrasound consistently shortened the time to 50% thrombolysis by one half. Furthermore, ultrasound increased the extent of fibrinolysis induced by t-PA (300 IU/ml) by as much as 30-50% in a buffer or plasma medium. Thus, under these experimental conditions, levels of plasminogen or inhibitors of plasmin or t-PA at concentrations found in normal plasma did not greatly influence the lysis of the clot once it had been formed. The major factors were the concentration of t-PA and whether or not the clot was exposed to ultrasound in addition to t-PA. Onundarson et a129 have also reported enhancement of t-PA-induced clot lysis in vitro by ultrasound delivered at a frequency of 1 MHz and an intensity as high as 8 W/cm2. The acceleration of fibrinolysis was not caused by thermal effects of the ultrasound, and the pattern of fibrin degradation products produced by the combination of ultrasound and t-PA was not different from that of t-PA alone.
In the rabbit jugular vein thrombosis model, ultrasound showed a trend toward enhancement of t-PAinduced fibrinolysis. Histological studies of jugular veins exposed to ultrasound did not reveal any significant changes, and serum CPK values were not altered by insonation. The use of ultrasound did not appear to increase the risk for significant pulmonary emboli resulting from clot lysis. Animals that received 2 mg t-PA combined with ultrasound developed a significant decrease in the levels of fibrinogen, although this was not associated with increased clot lysis compared with the animals receiving only 1 mg t-PA and ultrasound. Additional studies will be needed to determine whether ultrasound has a systemic effect on fibrinogen levels when used in combination with higher doses of t-PA.
There was no difference in clot lysis, which was approximately 50% when measured at 100 minutes, between the groups of rabbits that received 1 or 2 mg t-PA in the absence of ultrasound. Collen et al19 found that clot lysis was approximately 80% when measured at 6 hours in rabbits that had received 1 mg t-PA during 4 hours. This difference can be explained by the studies of Clozel et al,23 who showed that the effect of a given dose of t-PA is dependent on the timing of the administration (i.e., bolus versus 4-hour infusion). Furthermore, doses of t-PA that are higher than 0.4 mg/kg do not induce a dose-dependent fibrinolytic response in the rabbit jugular vein thrombosis model.2'
The time and duration of t-PA administration as well as the mode and frequency of ultrasound that are most efficacious in promoting clot lysis have yet to be established. The in vitro studies and the preliminary studies in the rabbit and the canine models, however, provide support for the potential use 
